Print PRINT
X
Phaco Technology: INFINITI® Vision System

Surgical Video Library

Take a closer look at the INFINITI® Vision System.

Alcon has compiled a comprehensive database of surgical videos demonstrating the enhanced phacoemulsification capabilities of the INFINITI® Vision System. Use this catalog of video segments for a closer look at any of the INFINITI® Vision System’s products, features, or procedures.

  • Browse by Surgeon: Videos are categorized by each performing surgeon and the topics he or she explores.
  • Browse by Technique: Videos are categorized by technique.

Surgical Video Library

Surgeon

Animation

ClearCut® S Safety Knife

Learn more about the benefits of ClearCut® technology.

Black, Brad

OZil® IP, INTREPID®, Single Hand Technique

Brad Black MD*

Cionni, Robert

OZil® IP, INTREPID®, Pre-Chop, AcrySof Toric IOL

Robert Cionni MD*

Condon, Gary

OZil® IP, INTREPID®, Divide and Conquer

Gary Condon MD*

Crandall, Alan

OZil® IP, INTREPID®, Pre-Chop

Alan Crandall MD*

Davidson, James A.

OZil® IP, INTREPID®, Divide and Conquer, Iris Retractors

James A. Davison MD*

Jones, Jason

OZil® IP, INTREPID®, Chop, Loose Zonules

Jason Jones MD*

Lane, Stephen

OZil® IP, INTREPID®, Modified Phaco Chop

Stephen Lane MD*

Lubeck, David

OZil® IP, INTREPID®, Chop

David Lubeck MD*

Mackool, Richard

OZil® IP, INTREPID®, Horizontal Chop

Richard Mackool MD*

Nordlund, Michael

OZil® IP, INTREPID®, Divide and Conquer

Michael Nordlund MD*

Osher, Robert

OZil® IP, 2.2 INTREPID®, Complex-Extreme Positive Pressure

Robert Osher MD*

Chapter 1 (09:28)

Chapter 2 (07:20)

Serafano, Donald

OZil® IP Defined Video

Donald Serafano MD*

OZil® IP, INTREPID®, Divide and Conquer

Donald Serafano MD*

AutoSert® IOL Injector Demonstration 1

Donald Serafano MD*

IOL implantation with AutoSert® IOL Injector, performed by Donald Serafano, MD.

AutoSert® IOL Injector Demonstration 2

Donald Serafano MD*

IOL implantation with AutoSert® IOL Injector, performed by Donald Serafano, MD.

AutoSert® IOL Injector Demonstration 3

Donald Serafano MD*

IOL implantation with AutoSert® IOL Injector, performed by Donald Serafano, MD.

Woodward, Lawrence

OZil® IP, INTREPID®, Divide and Conquer

Lawrence Woodard MD*

Technique

Automated IOL Injection

AutoSert® IOL Injector Demonstration 1

Donald Serafano MD*

IOL implantation with AutoSert® IOL Injector, performed by Donald Serafano, MD.

AutoSert® IOL Injector Demonstration 2

Donald Serafano MD*

IOL implantation with AutoSert® IOL Injector, performed by Donald Serafano, MD.

AutoSert® IOL Injector Demonstration 3

Donald Serafano MD*

IOL implantation with AutoSert® IOL Injector, performed by Donald Serafano, MD.

Chop

OZil® IP, INTREPID®, Chop

David Lubeck MD*

OZil® IP, INTREPID®, Chop, Loose Zonules

Jason Jones MD*

Complex-Extreme Positive Pressure

OZil® IP, 2.2 INTREPID®, Complex-Extreme Positive Pressure

Robert Osher MD*

Chapter 1 09:28)

Chapter 2 (07:20)

Divide and Conquer

OZil® IP, INTREPID®, Divide and Conquer

Donald Serafano MD*

OZil® IP, INTREPID®, Divide and Conquer

Gary Condon MD*

OZil® IP, INTREPID®, Divide and Conquer, Iris Retractors

James A. Davison MD*

OZil® IP, INTREPID®, Divide and Conquer

Lawrence Woodard MD*

OZil® IP, INTREPID®, Divide and Conquer

Michael Nordlund MD*

Horizontal Chop

OZil® IP, INTREPID®, Horizontal Chop

Richard Mackool MD*

Modified Phaco Chop

OZil® IP, INTREPID®, Modified Phaco Chop

Stephen Lane MD*

OZil® IP

OZil® IP Defined Video

Donald Serafano MD*

Pre-Chop

OZil® IP, INTREPID®, Pre-Chop, AcrySof Toric IOL

Robert Cionni MD*

OZil® IP, INTREPID®, Pre-Chop

Alan Crandall MD*

Safety Sharp Demo

ClearCut® S Safety Knife

Learn more about the benefits of ClearCut® technology.

Single Hand Technique

OZil® IP, INTREPID®, Single Hand Technique

Brad Black MD*

*These doctors are either consultants, speakers, or clinical investigators for Alcon.

X
View Important Product Information for
AcrySof® IQ Toric IOL+

ACRYSOF® IQ TORIC INTRAOCULAR LENSES IMPORTANT PRODUCT INFORMATION

CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.

INDICATIONS: The AcrySof® IQ Toric posterior chamber intraocular lenses are intended for primary implantation in the capsular bag of the eye for visual correction of aphakia and pre-existing corneal astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia, who desire improved uncorrected distance vision, reduction of residual refractive cylinder and increased spectacle independence for distance vision.

WARNINGS/PRECAUTIONS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Toric IOLs should not be implanted if the posterior capsule is ruptured, if the zonules are damaged, or if a primary posterior capsulotomy is planned. Rotation can reduce astigmatic correction; if necessary lens repositioning should occur as early as possible prior to lens encapsulation. All viscoelastics should be removed from both the anterior and posterior sides of the lens; residual viscoelastics may allow the lens to rotate.

Optical theory suggests that high astigmatic patients (i.e., > 2.5 D) may experience spatial distortions. Possible toric IOL related factors may include residual cylindrical error or axis misalignments. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure available from Alcon for this product informing them of possible risks and benefits associated with the AcrySof® IQ Toric Cylinder Power IOLs.

Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS® or BSS PLUS® Sterile Intraocular Irrigating Solutions.

ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions.

Click here to view the AcrySof® IQ Toric IOL Directions for Use (DFU).

ACRYSOF® IQ TORIC INTRAOCULAR LENSES IMPORTANT PRODUCT INFORMATION

CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.

INDICATIONS: The AcrySof® IQ Toric posterior chamber intraocular lenses are intended for primary implantation in the capsular bag of the eye for visual correction of aphakia and pre-existing corneal astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia, who desire improved uncorrected distance vision, reduction of residual refractive cylinder and increased spectacle independence for distance vision.

WARNINGS/PRECAUTIONS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Toric IOLs should not be implanted if the posterior capsule is ruptured, if the zonules are damaged, or if a primary posterior capsulotomy is planned. Rotation can reduce astigmatic correction; if necessary lens repositioning should occur as early as possible prior to lens encapsulation. All viscoelastics should be removed from both the anterior and posterior sides of the lens; residual viscoelastics may allow the lens to rotate.

Optical theory suggests that high astigmatic patients (i.e., > 2.5 D) may experience spatial distortions. Possible toric IOL related factors may include residual cylindrical error or axis misalignments. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure available from Alcon for this product informing them of possible risks and benefits associated with the AcrySof® IQ Toric Cylinder Power IOLs.

Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS® or BSS PLUS® Sterile Intraocular Irrigating Solutions.

ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions.

Click here to view the AcrySof® IQ Toric IOL Directions for Use (DFU).